![Dietmar Berger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dietmar Berger
President at INHIBRX, INC.
Profile
Dietmar P. Berger occupies the position of Chief Medical Officer & Global Head-Development at Sanofi. In his past career he held the position of Global Head-Research & Development at Atara Biotherapeutics, Inc., Head-Clinical Research Centre at Universitätsklinikum Freiburg, Vice President-Clinical Hematology & Oncology at Genentech, Inc. and Head-Clinical Research Centre at The Scripps Research Institute. Dr. Berger received a graduate degree and a doctorate from the University of Freiburg.
Latest news about Dietmar Berger
Dietmar Berger active positions
| Companies | Position | Start |
|---|---|---|
| INHIBRX, INC. | President | 29/05/2024 |
| GILEAD SCIENCES, INC. | Chief Tech/Sci/R&D Officer | 01/01/2025 |
| ARCUS BIOSCIENCES, INC. | Director/Board Member | 05/02/2025 |
University of Freiburg | Corporate Officer/Principal | - |
Former positions of Dietmar Berger
| Companies | Position | End |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 30/05/2019 |
Genentech, Inc.
 Genentech, Inc. Pharmaceuticals: MajorHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 30/04/2018 |
| SANOFI | Chief Tech/Sci/R&D Officer | - |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | Corporate Officer/Principal | - |
Universitätsklinikum Freiburg
 Universitätsklinikum Freiburg Hospital/Nursing ManagementHealth Services Universitätsklinikum Freiburg operates as a teaching hospital. The company was founded by Archduke Albrecht VI in 1457 and is headquartered in Freiburg, Germany. | Corporate Officer/Principal | - |
Training of Dietmar Berger
University of Freiburg | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Health Technology |
| SANOFI | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| ARCUS BIOSCIENCES, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. Pharmaceuticals: MajorHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Universitätsklinikum Freiburg
Universitätsklinikum Freiburg Hospital/Nursing ManagementHealth Services Universitätsklinikum Freiburg operates as a teaching hospital. The company was founded by Archduke Albrecht VI in 1457 and is headquartered in Freiburg, Germany. | Health Services |
Inhibrx, Inc.
 Inhibrx, Inc. BiotechnologyHealth Technology Inhibrx, Inc., is a clinical stage biotechnology company, focuses on developing pipeline of novel biologic therapeutic candidates. The firm’s pipeline is focused on oncology, orphan diseases and infectious diseases. It utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The company was founded by Mark Paul Lappe, Quinn Deveraux and Brendan P. Eckelman in April 2010 and is headquartered La Jolla, CA. | Health Technology |
- Stock Market
- Insiders
- Dietmar Berger
